Showing all 54 results
Amoxicillin & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, ultra-low moisture Alu-Alu blister strips (often containing integrated desiccants) to ensure the absolute stability of the incredibly hygroscopic Clavulanate salt.
Active Ingredient Strength Primary Clinical Function Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.500 mg
125 mg
(Total: 625 mg)Standard Adult Dose: Therapy for moderate RTIs, dental infections, and skin infections. Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.875 mg
125 mg
(Total: 1000 mg)High-Dose Adult Therapy: Aggressive intervention for severe pneumonia, severe sinus infections, and bite wounds. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Moisture Scavenger (Engineered for immediate gastric dissolution) *Pack Sizes: 1×6 or 1×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-7 day acute antibiotic regimens).
Cefadroxil 500 mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the beta-lactam ring.
Active Ingredient Strength Primary Clinical Function Cefadroxil Monohydrate USP/Ph.Eur. 500 mg (Equivalent to anhydrous Cefadroxil) Global Standard: Twice-daily adult therapy for pharyngitis, skin infections, and UTIs. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol / Magnesium Stearate Diluent / Superdisintegrant / Film-Coating (Engineered for rapid gastric dissolution and high bioavailability) Cefadroxil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Cefadroxil (as Monohydrate) USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections in adolescents. Cefadroxil (as Monohydrate) USP/Ph.Eur. 500 mg The Dermatology & UTI Payload: High-efficacy therapeutic dose for Cellulitis, Impetigo, and bladder infections. Excipients Proprietary Matrix High-Density Granulation: Engineered to manage the bulk of the 500mg payload while ensuring rapid disintegration and consistent absorption. Cefdinir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Cefdinir USP/Ph.Eur. 300 mg The Respiratory & Skin Anchor: The definitive therapeutic unit utilized for CAP, Sinusitis, and Skin/Soft Tissue Infections (SSTI). Excipients Proprietary Matrix Crystalline Form Stability: Engineered utilizing specialized binders to maintain the Crystalline Form I of Cefdinir, ensuring maximum shelf-life and predictable intestinal absorption. Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Linezolid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Gram-Negative Anchor: Broad-spectrum bactericidal activity against H. influenzae, E. coli, and Salmonella. Linezolid USP/Ph.Eur. 600 mg The Gram-Positive Powerhouse: Bacteriostatic activity against multi-drug resistant Staphylococci and Streptococci. Excipients Proprietary Matrix Advanced Disintegration System: Engineered utilizing Super-Disintegrants to manage the large 800mg+ active payload, ensuring the tablet shatters rapidly for maximum absorption. Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Cefixime Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime Trihydrate USP/Ph.Eur. 100 mg / 200 mg The Pediatric & Enteric Anchor: Dispersible format for easy administration in children and patients with dysphagia. Excipients Sweetening & Flavoring Agents Compliance Engineering: Formulated with high-grade fruit flavors and non-cariogenic sweeteners to mask the bitter antibiotic taste, ensuring 100% pediatric compliance. Disintegrants Super-Disintegrant Blend Instant-Dispersible Matrix: Engineered to shatter and form a smooth, grit-free suspension in < 45 seconds when placed in 5-10 mL of water. Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the trihydrate salt.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Standard Primary Care Anchor: Utilized for uncomplicated UTIs, Otitis Media, and Pharyngitis. Cefixime (as Trihydrate) USP/Ph.Eur. 400 mg The Enteric & Gonorrhea Payload: High-efficacy therapeutic dose for Typhoid Fever and uncomplicated Gonorrhea. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing Laser Micronization of the API to ensure rapid dissolution and 100% bioequivalence to the innovator brand. Cefopodoxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 100 mg The Pediatric & Titration Anchor: Ideal for Pharyngitis, Tonsillitis, and uncomplicated UTIs in adolescents and adults. Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The Respiratory Macrodose: High-efficacy payload for Community-Acquired Pneumonia and Sinusitis. Excipients Proprietary Matrix Solubility Enhancement: Engineered utilizing micronized API and specialized surfactants to overcome the naturally poor solubility of the Proxetil salt. Cefpodoxime & Clavulanic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime Proxetil Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 50 mg / 100 mg The Pediatric & Titration Anchor: Dispersible format for easy administration in children and elderly patients with swallowing difficulties. Excipients Sweetening & Flavoring Agents Bitter-Shield Technology: Engineered with molecular masking agents (e.g., Cyclodextrins) to neutralize the intense bitterness of the API, ensuring 100% pediatric compliance. Disintegrants Croscarmellose Sodium / SSG Instant-Dispersible Matrix: Engineered to shatter and form a uniform suspension in < 60 seconds when placed in 5-10 mL of water. Cefpodoxime-Potassium-Clavulanate-Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefprozil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-Alu blister strips to prevent hydrolytic degradation.
Active Ingredient Strength Primary Clinical Function Cefprozil USP/Ph.Eur. 250 mg The Pediatric & Mild Infection Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections. Cefprozil USP/Ph.Eur. 500 mg The Respiratory & SSTI Macrodose: Utilized for Acute Sinusitis, secondary infections of Bronchitis, and complicated skin infections. Excipients Proprietary Matrix Hydrolysis-Resistant Formulation: Engineered utilizing high-density granulation to protect the monohydrate API from environmental moisture. Cefuroxime Axetil Tablets
FreeProduct Composition & StrengthWe supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Utilized for Acute Otitis Media, Pharyngitis, and uncomplicated UTIs. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: Utilized for Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Proprietary Matrix Amorphous Solid Dispersion Technology: Engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates. Cefuroxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips to ensure the stability of the hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur.
(Equivalent to Cefuroxime)250 mg The Pediatric & ENT Anchor: The definitive unit utilized for the treatment of Acute Otitis Media, Pharyngitis, and uncomplicated Urinary Tract Infections. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: The high-efficacy therapeutic payload required for the management of Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Colloidal Silicon Dioxide / Premium Polymeric Film Diluent / Superdisintegrant / Solubilizer / Glidant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion Technology. Because crystalline Cefuroxime Axetil has near-zero bioavailability, our tablets are engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates). *Pack Sizes: 1×6, 1×10, or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-10 day acute curative regimens).
Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is critical to mask the intensely bitter taste of the drug. Note: Dosing is often calculated based on the “Base” content.
Active Ingredient (Salt) Equivalent Base Primary Role Chloroquine Phosphate USP/BP 250 mg ~ 155 mg Base Prophylaxis / Maintenance Chloroquine Phosphate USP/BP 500 mg ~ 310 mg Base Acute Malaria Treatment Excipients Q.S. Starch / Magnesium Stearate Co -Trimoxazole Tablets Tablet
FreeCo- Trimoxazole Tablets IP
Trimethoprime & Sulphamethoxazole Tablets IP
Each Uncoated tablet contains :
Trimethoprime IP 20 mg
Sulphamethoxazole IP 100 mgTrimethoprim & sulphamethoxazole tablets IP Co -trimoxazole Tablets IP
Each film coated tablets : Excipients q.s
Trimethoprim IP 80 mg
Sulphamethoxazole IP 400 mgTrimethoprim & sulphamethoxazole tablets IP
Each film coated tablets :
Trimethoprim IP 160 mg
Sulphamethoxazole IP 800 mgCo – Trimoxazole Tablets BP
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated Tablet contains :
Trimethoprim BP 80 mg
Sulfamethoxazole BP 400 mgTACOT – DS
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated tablet contains :
Trimethoprim BP 160 mg
Sulphamethoxazole BP 800 mgUsage: – Traveler’s diarrhea
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Dapsone Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White). The range of strengths allows for precise dosing in both leprosy programs and dermatological maintenance.
Active Ingredient Strength (Standard) Primary Role Dapsone USP/BP 25 mg Pediatric / Initiation Dapsone USP/BP 50 mg Intermediate Dose Dapsone USP/BP 100 mg Standard Adult MDT Dose Excipients Q.S. Magnesium Stearate / Starch Ethambutol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often Gray or White). Coating is essential as the API is hygroscopic and has a bitter taste.
Active Ingredient Strength (Standard) Primary Role Ethambutol HCl USP/BP/IP 200 mg Pediatric / Renal Adjustment Ethambutol HCl USP/BP/IP 400 mg Standard Adult Unit Ethambutol HCl USP/BP/IP 600 mg High Strength (Daily Regimen) Ethambutol HCl USP/BP/IP 800 mg Intensive Phase Loading Ethionamide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Yellow/Orange). Effective coating is mandatory as the drug causes significant gastric irritation and has a metallic taste.
Active Ingredient Strength (Standard) Target Patient Ethionamide USP/BP/IP 250 mg Standard Adult / Pediatric Unit Excipients Q.S. Microcrystalline Cellulose / Hypromellose Isoniazid Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (White/Scored). It is often co-administered with Pyridoxine (Vitamin B6) to prevent nerve damage.
Active Ingredient Strength (Standard) Target Patient Isoniazid USP/BP/IP 100 mg Pediatric / Prophylaxis Isoniazid USP/BP/IP 300 mg Standard Adult Dose Excipients Q.S. Binder / Disintegrant Ivermectin Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Scored). The dosage is strictly weight-based.
Active Ingredient Strength (Standard) Role Ivermectin USP/BP/EP 3 mg Pediatric / Low Body Weight Ivermectin USP/BP/EP 6 mg Standard Adult Unit Ivermectin USP/BP/EP 12 mg High Strength (Adult Dose) Excipients Q.S. Microcrystalline Cellulose (Filler) Metronidazole Tablet
FreeProduct Composition & Available Strengths
We supply Metronidazole in standard, internationally recognized strengths optimized for adult and pediatric treatment regimens.
Active Ingredient Available Strengths Common Dosage Matrix Primary Clinical Target Metronidazole BP / IP / USP 200 mg Film-Coated / Uncoated Oral Tablet Pediatric & Low-Dose Titration: For delicate adjustments in mild amoebic dysentery or combination protocols. Metronidazole BP / IP / USP 400 mg Film-Coated / Uncoated Oral Tablet Standard Generic Backbone: Standard twice or thrice-daily dosing for dental abscesses and Giardiasis. Metronidazole BP / IP / USP 500 mg High-Potency Oral Tablet Institutional Target: High-volume strength preferred for anaerobic surgical prophylaxis and severe trichomoniasis. Moxifloxacin & Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive antibiotic compounds.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg 4th-Gen Fluoroquinolone: Deep tissue and lung penetration to eradicate DNA replication in resistant respiratory and intra-abdominal pathogens. Cefixime (as Trihydrate) Ph.Eur./USP 400 mg 3rd-Gen Cephalosporin: Massive Gram-negative cell wall destruction, specifically targeting enteric pathogens like Salmonella typhi. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic Cefixime Trihydrate and mask the intensely bitter taste of Moxifloxacin) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 7-to-14 day acute critical-care anti-infective dispensing regimens).
Moxifloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg Global Pulmonology Standard: High-dose adult therapy for the aggressive eradication of resistant respiratory, skin, and intra-abdominal pathogens. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the highly hygroscopic API and completely mask its intensely bitter taste) *Pack Sizes: 1×5 or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-14 day acute critical-care dispensing regimens).
Nalidixic Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The formulation is engineered for rapid disintegration to ensure the active ingredient is quickly processed for renal excretion.
Active Ingredient Strength (Standard) Therapeutic Role Nalidixic Acid BP/USP 500 mg Quinolone Antibacterial Excipients Q.S. Maize Starch / Gelatin Binder & Disintegrant Coating (Optional) Q.S. HPMC / Titanium Dioxide Film Coating Nitrofurantoin Tablets
FreeA Nitrofurantoin tablet is an antibiotic specifically used to treat and prevent urinary tract infections (UTIs), such as cystitis. It works by damaging the DNA of bacteria in the urinary tract.
Norfloxacin & Tinidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Norfloxacin USP/Ph.Eur. 400 mg Aerobic Gut/UTI Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Tinidazole USP/Ph.Eur. 600 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and pelvic anaerobes. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute anti-infective dispensing regimens).
Ofloxacin & Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredients.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Aerobic Standard: Broad-spectrum eradication of Gram-negative/positive bacteria driving acute gastroenteritis and genitourinary infections. Ornidazole INN/Ph.Eur. 500 mg Anaerobic/Protozoal Standard: Highly tolerable eradication of tissue-invasive amoebas, giardia, and surgical-site anaerobes. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Premium Opaque Film-Coating (Engineered specifically to form an impenetrable barrier that completely masks the notoriously bitter, metallic taste of both APIs, guaranteeing patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-5 day acute anti-infective dispensing regimens).
Ofloxacin Tablets
FreeOfloxacin Tablets 200 mg
Each Filmcoated tablet contains :
Ofloxacin IP 200 mg
Excipients q.sYALLEY FLOX
Ofloxacin Tablets 200mg Each Film coated tablet contains :
Ofloxacin BP 200 mg
Excipients q.sOfnis -200
Ofloxacin Tablets
Each Filmcoated tablet contains :
Ofloxacin BP 200 mgUsage: – Treat bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Ornidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or Alu-PVC blister strips to ensure the absolute chemical stability of the highly photolabile active ingredient.
Active Ingredient Strength Primary Clinical Function Ornidazole INN/Ph.Eur. 500 mg Global Clinical Standard: Base therapeutic unit for the rapid eradication of protozoal and anaerobic pathogens. Excipients Microcrystalline Cellulose / Maize Starch / Sodium Starch Glycolate / Hypromellose / Titanium Dioxide Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to create an impenetrable barrier that completely masks the notoriously bitter, foul taste of the nitroimidazole API, ensuring flawless patient compliance) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-10 day acute anti-infective dispensing regimens).
Praziquantel Tablets
FreePraziquantel Tablets USP 600 mg
Each Film Coated Tablet Contains:
Praziquantel USP 600 mgUsage: – Treat infections of certain parasites
Category: – Anthelmintic drugs
Therapeutic category: – Anthelmintic, Antiprotozoal, Antiparasitic
Secnidazole Tablets
FreeSecnidazole Tablets IP 500 mg
Each Filmcoated tablet contains :
Secnidazole IP 500 mgSecnidazole Tablets I.P.
Each Filmcoated tablet contains :
Secnidazole IP 1 gmSeczole -2 Secnidazole Tablets IP 2 gm
Each film coated tablet contains:
Secnidazole IP 2 gmUsage: – treat vaginal infection (vaginosis) caused by bacteria
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Tinidazole Tablet
FreeTinidazole Tablets
Each Filmcoated tablet contains :
Tinidazole BP 500 mgUsage: – treat infections caused by protozoa
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic, Anthelmintic, Antiprotozoal, Antiparasitic























